Eli Lilly (LLY)Officer sold ~$2.88M

~$2.88M

Approx. value · 2,500 sh @ $1,150.77

30K

Holds after · shares reported

Traded

Jun 10, 2026

Filed

Jun 11, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 2, 2025CongressDisclosed sale of LLY — reported range $1,001 - $15,000
2. Jan 2, 2026CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
3. Mar 27, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
4. Apr 2, 2026Congress · 1 personMembers of Congress: 2 purchases
5. Apr 8, 2026CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
6. Apr 14, 2026CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
7. Apr 20, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.7%
8. Apr 30, 2026Company filing · Form 8-K · ResultsReported its results
9. May 1, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.5%
10. May 6, 2026Insider · 1 personInsiders: 2 sales (~$15.8M)
11. May 15, 2026Federal contract · $52K obligatedDepartment of Veterans Affairs awarded Eli Lilly: $52K obligated to date
12. Jun 9, 2026FDAFDA drug approval: Ebglyss
13. Jun 10, 2026 · this disclosureInsider · Their largest sale since 2022Officer sold ~$2.88M of LLY shares in the open market

What came next

1. Jun 10, 2026Congress · 1 personMembers of Congress: 2 purchases
2. Jul 1, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
3. Jul 10, 2026CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
4. Jul 13, 2026FDAFDA drug approval: Verzenio
5. Jul 14, 2026FDAFDA drug approval: Retevmo
6. Jul 14, 2026FDAFDA drug approval: Retevmo
7. Jul 23, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.6%
8. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
9. Aug 7, 2026InsiderOfficer sold ~$5.95M of LLY shares in the open market
10. Aug 10, 2026Insider · Their largest sale since 2014Officer sold ~$2.37M of LLY shares in the open market
11. Aug 17, 2026Federal contract · $5K obligatedDepartment of Veterans Affairs awarded Eli Lilly: $4.5K obligated to date
12. Aug 17, 2026Insider · Their largest sale since 2022Officer sold ~$7.64M of LLY shares in the open market
13. Aug 26, 2026FDAFDA drug approval: Zepbound
14. Aug 27, 2026FDAFDA drug approval: Mounjaro
15. Aug 27, 2026FDAFDA drug approval: Mounjaro
16. Sep 18, 2026FDAFDA drug approval: Inluriyo
17. Sep 18, 2026FDAFDA drug approval: Verzenio
18. Sep 23, 2026FDAFDA drug approval: Onswik
19. Sep 25, 2026FDAFDA drug approval: Olumiant

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Eli Lilly

For Eli Lilly, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports, 189 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LLY page.

Other recent filings by Ilya Yuffa, EVP&Pres, LLY USA&Global Capab

• SEC Form 4 at Eli Lilly (LLY)Aug 12, 2025
• SEC Form 4 at Eli Lilly (LLY)May 15, 2025

The full history of Ilya Yuffa, EVP&Pres, LLY USA&Global Capab is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Eli Lilly

• SEC Form 144Oct 7, 2026
• USAspending.gov award recordSep 1, 2026
• SEC Form 13F-HRAug 26, 2026
• SEC Form 13F-HRAug 25, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 13F-HRAug 18, 2026

Everything OQRO holds on this company is on its LLY page.